Double-acylated GLP-1 derivatives

Details for Australian Patent Application No. 2010338387 (hide)

Owner Novo Nordisk A/S

Inventors Garibay, Patrick William; Spetzler, Jane; Kodra, Janos Tibor; Linderoth, Lars; Lau, Jesper; Sauerberg, Per

Agent Shelston IP

Pub. Number AU-A-2010338387

PCT Pub. Number WO2011/080103

Priority 09179390.1 16.12.09 EP; 61/288,601 21.12.09 US

Filing date 16 December 2010

Wipo publication date 7 July 2011

International Classifications

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/080103 Priority application(s): WO2011/080103

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010338399-Pressure enhancing device

2010338383-Method for joining fibre-containing composite materials